Memory Pharmaceuticals Corp. (MEMY) is in the Pharma Industry

• Sort by

• Memory Pharmaceutical Q4 2007 Earnings Call Transcript

  Memory Pharmaceutical Q4 2007 Earnings Call Transcript

  Earnings calls 2008-03-19

  Tags: Memory Pharmaceuticals Corp., Call Transcript, Earnings, Seeking Alpha, Financial Accounting, Finance

Additional Resources

• Memory Pharmaceuticals Closes Second Tranche of Equity Financing with The Stanley Medical Research Institute

  - Results in Proceeds of $2 Million - MONTVALE, N.J., June 24 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. today announced that it has secured $2 million through the sale of approximately 4.7 million shares of common stock under its equity financing agreement with an investment group led...

  Articles 2008-06-24

• Memory Pharmaceuticals Receives Anticipated NASDAQ Staff Determination Letter

  - Company to Request a Hearing - MONTVALE, N.J., June 9 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. today announced that on June 6, 2008 it received a letter from the NASDAQ Listing Qualifications Department notifying the Company that, because it has not regained compliance with the $1.00...

  Articles 2008-06-09

• Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day

  MONTVALE, N.J., May 16 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. today announced progress with several key development programs at its R&D Day meeting with the investment community. The Company reported new clinical data for MEM 1414, its lead PDE4 inhibitor, demonstrating the compound's CNS activity in humans. ...

  Articles 2008-05-16

• Memory Pharmaceuticals Reports First Quarter 2008 Financial Results

  MONTVALE, N.J., May 14 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. today reported its financial results for the first quarter ended March 31, 2008. "We had a productive start to 2008, reporting significant progress with our collaborations and refocusing our operations to advance four high-value programs," said Vaughn...

  Articles 2008-05-14

• Memory Pharmaceuticals to Host R&D Day on May 16, 2008

  MONTVALE, N.J., May 12 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. , today announced that it will host an R&D Day for the investment community on Friday, May 16, 2008 in New York City. Presentations will begin at 9:00 a.m. EDT and will focus on the Company's progress with its nicotinic...

  Articles 2008-05-12

• Memory Pharmaceuticals to Announce First Quarter 2008 Results on Wednesday, May 14, 2008

  MONTVALE, N.J., May 7 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. announced today that it will report its first quarter 2008 financial results on Wednesday, May 14, 2008, before the U.S. financial markets open. Management will provide a Company update and discuss the first quarter results during a conference...

  Articles 2008-05-07

• Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals' Nicotinic Alpha-7 Agonist, MEM 3454

  -Memory Receives $6 Million Milestone Payment- -Memory to Host Conference Call at 9:00 a.m. EDT Today- MONTVALE, N.J. and BASEL, Switzerland, May 2 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. and Roche today announced that Roche has exercised its option to further develop and commercialize...

  Articles 2008-05-02

• Memory Pharmaceuticals Corp. Changes and Reallocates Programs.

  M2 PRESSWIRE-12 March 2008-NASDAQNEWS: Memory Pharmaceuticals Corp. Changes and Reallocates ProgramsC1994-2008 M2 COMMUNICATIONS LTD RDATE:13032008 InvestorIM has been created as a tool for the average investor. The idea is simple, a website where the world can communicate. Do you have...

  Articles 2008-03-12

• Has added Memory Pharmaceuticals Corp. to their watch list.

  M2 PRESSWIRE-12 March 2008-The Maybach Review: Has added Memory Pharmaceuticals Corp. to their watch listC1994-2008 M2 COMMUNICATIONS LTD RDATE:12032008 Maybach Financial is a syndicate of financial informants representing a true investing experience. Taking research from financial consultants, brokers,...

  Articles 2008-03-12

• Memory Pharmaceuticals Corp. Reports the Fourth Quarter and Year end Results.

  M2 PRESSWIRE-7 March 2008-NASDAQNEWS: Memory Pharmaceuticals Corp. Reports the Fourth Quarter and Year end ResultsC1994-2008 M2 COMMUNICATIONS LTD RDATE:07032008 InvestorIM has been created as a tool for the average investor. The idea is simple, a website where the world...

  Articles 2008-03-07

• Has added Memory Pharmaceuticals Corp. to their watch list.

  M2 PRESSWIRE-7 March 2008-MG Strategies: Has added Memory Pharmaceuticals Corp. to their watch listC1994-2008 M2 COMMUNICATIONS LTD RDATE:07032008 Maybach Financial is a syndicate of financial informants representing a true investing experience. Taking research from financial consultants, brokers, researchers,...

  Articles 2008-03-07

• Global Market Review on Memory Pharmaceuticals Corp.

  M2 PRESSWIRE-6 March 2008-Market Review: Global Market Review on Memory Pharmaceuticals Corp.C1994-2008 M2 COMMUNICATIONS LTD RDATE:06032008 Streetinvesting.com has now resumed our progressive review of Memory Pharmaceuticals Corp. (Nasdaq: MEMY) after it traded down 8% Thursday, late in the morning...

  Articles 2008-03-06

• Has added Memory Pharmaceuticals Corp. to their watch list.

  M2 PRESSWIRE-29 February 2008-NASDAQNEWS: Has added Memory Pharmaceuticals Corp. to their watch listC1994-2008 M2 COMMUNICATIONS LTD RDATE:29022008 InvestorIM has been created as a tool for the average investor. The idea is simple, a website where the world can communicate....

  Articles 2008-02-29

• Progressive Review for Memory Pharmaceuticals Corp.

  M2 PRESSWIRE-28 February 2008-Market Review: Progressive Review for Memory Pharmaceuticals Corp.C1994-2008 M2 COMMUNICATIONS LTD RDATE:28022008 Streetinvesting.com has now resumed our progressive review of Memory Pharmaceuticals Corp. (Nasdaq: MEMY) after it traded unchanged Thursday, early in the afternoon with below...

  Articles 2008-02-28

• Has added Memory Pharmaceuticals Corp. to their watch list.

  M2 PRESSWIRE-28 February 2008-The Maybach Review: Has added Memory Pharmaceuticals Corp. to their watch listC1994-2008 M2 COMMUNICATIONS LTD RDATE:28022008 Maybach Financial is a syndicate of financial informants representing a true investing experience. Taking research from financial consultants, brokers,...

  Articles 2008-02-28

• Introduces Memory Pharmaceuticals to our Bluechips Radar.

  M2 PRESSWIRE-20 February 2008-IST Market Review: Introduces Memory Pharmaceuticals to our Bluechips RadarC1994-2008 M2 COMMUNICATIONS LTD RDATE:20022008 International Stock Targets is a world renowned independent research firm, based in Johannesburg, South Africa. Along with walking investors through the whole...

  Articles 2008-02-20

• Introduces Memory Pharmaceuticals to our Bluechips Portfolio.

  M2 PRESSWIRE-7 February 2008-IST Targets: Introduces Memory Pharmaceuticals to our Bluechips PortfolioC1994-2008 M2 COMMUNICATIONS LTD RDATE:07022008 International Stock Targets is a world renowned independent research firm, based in Johannesburg, South Africa. Along with walking investors through the whole...

  Articles 2008-02-07

• Has added Memory Pharmaceuticals Corp. to their watch list.

  M2 PRESSWIRE-6 February 2008-The Maybach Review: Has added Memory Pharmaceuticals Corp. to their watch listC1994-2008 M2 COMMUNICATIONS LTD RDATE:06022008 Maybach Financial is a syndicate of financial informants representing a true investing experience. Taking research from financial consultants, brokers,...

  Articles 2008-02-06

• Progressive Market Review for Memory Pharmaceuticals Corp.

  M2 PRESSWIRE-6 February 2008-The SI Report: Progressive Market Review for Memory Pharmaceuticals Corp.C1994-2008 M2 COMMUNICATIONS LTD RDATE:06022008 Streetinvesting.com has now resumed our progressive review of Memory Pharmaceuticals Corp. (Nasdaq: MEMY) after it traded up 23% Wednesday early in...

  Articles 2008-02-06